Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.51
-0.02 (-0.36%)
At close: Mar 6, 2026, 4:00 PM EST
5.40
-0.11 (-2.00%)
After-hours: Mar 6, 2026, 7:42 PM EST
Compass Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 992 | 955 | 200 | 199 | 633 | 309 | |
| Market Cap Growth | 134.15% | 378.75% | 0.34% | -68.61% | 105.02% | - | |
| Enterprise Value | 793 | 745 | 71 | 37 | 516 | 292 | |
| Last Close Price | 5.51 | 5.37 | 1.45 | 1.56 | 5.03 | 3.17 | |
| PS Ratio | - | - | 234.71 | - | - | - | |
| PB Ratio | 4.99 | 4.85 | 1.59 | 1.34 | 3.49 | 2.21 | |
| P/TBV Ratio | 5.04 | 4.85 | 1.59 | 1.34 | 3.49 | 2.21 | |
| EV/Sales Ratio | - | - | 83.51 | - | - | - | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.01 | 0.02 | 0.03 | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -0.96 | -1.01 | -1.01 | -1.00 | |
| Net Debt / EBITDA Ratio | 2.74 | 2.74 | 2.14 | 3.04 | 4.49 | 4.58 | |
| Net Debt / FCF Ratio | 4.05 | 4.05 | 2.68 | 3.71 | 5.35 | 6.52 | |
| Asset Turnover | - | - | 0.01 | - | - | - | |
| Quick Ratio | 14.96 | 14.96 | 14.28 | 19.54 | 11.54 | 13.59 | |
| Current Ratio | 15.02 | 15.02 | 14.96 | 19.73 | 12.05 | 13.84 | |
| Return on Equity (ROE) | -41.29% | -41.29% | -36.07% | -25.74% | -24.39% | -91.30% | |
| Return on Assets (ROA) | -25.29% | -25.29% | -23.81% | -17.66% | -14.73% | -19.00% | |
| Return on Capital Employed (ROCE) | -35.40% | -35.40% | -43.10% | -33.80% | -22.70% | -21.80% | |
| Earnings Yield | -6.70% | -6.96% | -24.75% | -21.37% | -6.19% | -26.60% | |
| FCF Yield | -4.96% | -5.15% | -22.50% | -20.44% | -5.42% | -6.98% | |
| Buyback Yield / Dilution | -14.78% | -14.78% | -8.15% | -20.76% | -67.31% | -104.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.